ADALIMUMAB DISCONTINUATION IN PATIENTSWITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION

被引：0
|
作者：
Demidova, Natalia [1 ]
Savushkina, Natalia [1 ]
Galushko, Elena [1 ]
Gordeev, Andrey [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Early Arthrit, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.4054
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0374
引用
收藏
页码：1647 / 1647
页数：1
相关论文
共 50 条
  • [1] Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
    Tanaka, Yoshiya
    Hirata, Shintaro
    Kubo, Satoshi
    Fukuyo, Shunsuke
    Hanami, Kentaro
    Sawamukai, Norifumi
    Nakano, Kazuhisa
    Nakayamada, Shingo
    Yamaoka, Kunihiro
    Sawamura, Fusae
    Saito, Kazuyoshi
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 389 - 395
  • [2] Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity
    Harigai, Masayoshi
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Matsubara, Tsukasa
    Yamanaka, Hisashi
    Miyasaka, Nobuyuki
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (06) : 814 - 822
  • [3] Discontinuation of Adalimumab without Functional and Radiographic Damage Progression After Achieving Sustained Remission in Patients with Rheumatoid Arthritis (the HONOR study): 1-Year Results.
    Tanaka, Yoshiya
    Hirata, Shintaro
    Fukuyo, Shunsuke
    Nawata, Masao
    Kubo, Satoshi
    Yamaoka, Kunihiro
    Saito, Kazuyoshi
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S333 - S333
  • [4] Discontinuation of Adalimumab Without Functional and Structural Progress After Attaining Remission in Patients with Rheumatoid Arthritis
    Tanaka, Yoshiya
    Hirata, Shintaro
    Fukuyo, Shunsuke
    Nawata, Masao
    Kubo, Satoshi
    Yamaoka, Kunihiro
    Saito, Kazuyoshi
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S962 - S962
  • [5] Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
    Kimura, Noriko
    Suzuki, Katsuya
    Takeuchi, Tsutomu
    [J]. INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [6] Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
    Noriko Kimura
    Katsuya Suzuki
    Tsutomu Takeuchi
    [J]. Inflammation and Regeneration, 39
  • [7] DISCONTINUATION OF TOCILIZUMAB AFTER ATTAINING REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Nampei, A.
    Nagayama, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 877 - 877
  • [8] Discontinuation of DMARD after remission in patients with rheumatoid arthritis.
    Park, YB
    Kim, JM
    Lee, SK
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S277 - S277
  • [9] Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study (vol 74, pg 389, 2015)
    Tanaka, Y.
    Hirata, S.
    Kubo, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (07) : E46 - E46
  • [10] Time-course Ultrasonography to Predict Flare After Discontinuation of Biologics in Patients with Rheumatoid Arthritis Achieving Stringent Remission
    Ogura, Takehisa
    Katagiri, Takaharu
    Takakura, Yuto
    Imaizumi, Chihiro
    Kameda, Hideto
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2485 - 2486
12345